<DOC>
	<DOCNO>NCT03084523</DOCNO>
	<brief_summary>Cerebrovascular disease major source neural injury urgent need comprehensive evaluation patient . High-resolution MRI ( HR-MRI ) allow direct visualization intracranial vessel wall pathology set acute ischemic stroke intracranial aneurysm ( intracranial aneurysm rupture.Vessel wall enhancement HR-MRI result inflammation considerable potential marker future stroke risk aneurysm rupture . The investigator ( ) successfully develop employ intracranial HR-MRI protocol identify vessel-wall enhancement 130 patient past year ; however , finalize protocol current lack data HR-MRI interrater reliability , vessel-wall enhancement prevalence symptomatic asymptomatic patient , local systemic inflammation underpin vessel-wall enhancement pathophysiology . The unmet need study validate HR-MRI reliability association vessel-wall enhancement symptomatic pro-inflammatory status patient cerebrovascular disease .</brief_summary>
	<brief_title>High-resolution MRI Inflammation Intracranial Arterial Vessel Wall</brief_title>
	<detailed_description>Intracranial atherosclerosis account 10 40 % , depend ethnicity , 700,000 ischemic stroke United States every year.The annual rate recurrent stroke patient optimally treat Intracranial atherosclerosis remain twice average stroke etiology ( 12.5 % vs. 5 % ) .Intracranial aneurysm rupture affect 30,000 Americans every year 50 % patient die within month intracranial aneurysm rupture.7 A robust literature establish HR-MRI extracranial carotid vessel wall enhancement predict stroke , independent stenosis . Vessel wall enhancement report symptomatic Intracranial atherosclerosis intracranial aneurysm role local systemic inflammation unknown . Inflammatory biomarkers elevate symptomatic extracranial atherosclerosis unstable intracranial aneurysm , association HR-MRI finding Intracranial atherosclerosis intracranial aneurysm yet explored.Vessel wall enhancement typically demonstrate uptake gadolinium MRI contrast aneurysm wall atherosclerotic plaque . A novel MRI contrast agent , ferumoxytol , allow multicontrast weight T1w T2w image provide important insight role local vessel wall inflammation accumulate macrophage delay T2* sequence . To identify effective prevention treatment strategy cerebrovascular disease , investigator ( ) need critically evaluate HR-MRI technique , determine vessel wall enhancement prevalence , explore link vessel wall enhancement inflammation . The investigator ( ) hypothesize vessel wall enhancement reliable , associate symptomatic Intracranial atherosclerosis/intracranial aneurysm high level inflammatory biomarkers . In order answer hypothesis , investigator ( ) propose pilot study 40 participant . The investigator ( ) opportunistically enroll participant receive standard care HR-MRI gadolinium contrast perform baseline HR-MRI gadolinium need . All participant 2 study HR-MRIs ( 0 72 hour ) use ferumoxytol contrast . The investigator ( ) analyze two group participant ( 20 intracranial atherosclerosis 20 intracranial aneurysm ) 10 asymptomatic 10 symptomatic participant group .</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Ferrosoferric Oxide</mesh_term>
	<criteria>40 patient enrol prospective crosssectional study 2 cohort : ( A ) Intracranial atherosclerosis &amp; ( B ) Intracranial aneurysm ( A ) cohort : 20 intracranial atherosclerosis ( stenosis le 25 % ) participant : 10 asymptomatic 10 recent ischemic stroke ( less equal 7 day ) ( B ) cohort : 20 intracranial aneurysm patient participant : 10 asymptomatic 10 recent intracranial aneurysm ( ) rupture ( less equal 7 day ) . Less 18 year old Documented history atrial fibrillation ( intracranial atherosclerosis cohort ) . Carotid stenosis great 70 % ( intracranial atherosclerosis cohort ) . Pregnant woman Contrast allergy Acute chronic kidney disease glomerular filtration rate &lt; 30 ml/min/1.73m2 Intravenous iron sensitivity Serum ferritin transferrin saturation ageadjusted upper limit normal . If serum ferritin normal , transferrin saturation normal , patient exclude . Pacemaker MRI contraindication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>